'Universal' influenza vaccine development underway in Europe

December 4, 2013
Development of a 'universal' influenza vaccine underway in Europe
Credit: Shutterstock

A newly launched European project is set to take a major step toward the development of a universal flu vaccine. It aims to counter the emergence of new strains and seasonal epidemics.

The viral infection usually strikes in colder months with being responsible for around 3 - 5 million cases of severe illness and 250,000 to 500,000 deaths worldwide.

Due to its rapid spread particularly among high risk population groups, remains a serious public health problem. To date, the most effective way to prevent the disease or severe symptoms is annual vaccination but current vaccines only offer limited protection against evolving strains of the infection.

To overcome these weaknesses, a public-private partnership comprising seven renowned organisations from Europe joined forces under the EDUFLUVAC project to develop a broad-spectrum, long-lasting against influenza.

EDUFLUVAC launched into action only a month ago and aims to take a novel approach by 'educating' the immune system to cross-recognise common regions within multiple strains.

'Developing a universal has become a global health priority for preventing the spread of the virus and the emergence of new strains, and we are convinced that EDUFLUVAC will be a major step forward towards achieving this goal', says Othmar Engelhardt, principal investigator at the National Institute for Biological Standards and Control, United Kingdom.'

The research team expects to achieve better protection against epidemic influenza through the development of a vaccine that would not only offer the tremendous advantage of eliminating the need for a seasonal vaccine every year but could also reduce the need for costly annual vaccination campaigns.

Odile Leroy, Executive Director of the European Vaccine Initiative and coordinator of EDUFLUVAC, says: 'Low and middle-income countries currently have minimal programmes. Thus, the development of a vaccine that elicits broad long-lasting defence would facilitate vaccination campaigns and confer protection against influenza in hitherto untargeted groups with limited health care'.

The four-year project is coordinated by the European Vaccine Initiative headquartered in Germany and was awarded a grant of EUR 4.6 million in EU funding.

Explore further: Study suggests potential hurdle to universal flu vaccine development may be overcome

More information: Project factsheet: cordis.europa.eu/projects/rcn/110279_en.html

Related Stories

Study suggests potential hurdle to universal flu vaccine development may be overcome

August 15, 2012
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...

Novel approach for influenza vaccination shows promise in early animal testing

May 22, 2013
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine concept, which ...

Prediction of seasonal flu strains improves chances of universal vaccine

March 12, 2013
(Medical Xpress)—Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease.

First vaccine against four flu strains ready to ship

August 6, 2013
(HealthDay)—The U.S Food and Drug Administration has approved shipping of the first vaccine to protect against four strains of seasonal flu.

FDA approves H5N1 avian influenza vaccine

November 26, 2013
(HealthDay)—The U.S. Food and Drug Administration has approved the first adjuvanted vaccine for the prevention of H5N1 influenza in adults at greater-than-average risk of exposure.

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

New insights into the world of trypanosomes

August 23, 2017
Single specimens of the vermicular pathogens causing sleeping sickness swim inside the gut of the tsetse fly between blood cells which the fly has ingested from an infected mammal. This is where they start their week-long ...

Survey of DNA fragments circulating in the blood suggests vast microbial diversity

August 23, 2017
A new survey of DNA fragments circulating in human blood suggests our bodies contain vastly more diverse microbes than anyone previously understood. What's more, the overwhelming majority of those microbes have never been ...

Study a breakthrough in understanding chronic pain in children

August 23, 2017
A University of Calgary psychologist who studies pediatric pain has made a breakthrough in understanding the cause of chronic pain in adolescents—by focusing on those recovering from major surgeries.

Scientists develop infection model for tickborne flaviviruses

August 22, 2017
National Institutes of Health (NIH) scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a ...

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Fatty liver can cause damage to other organs via crosstalk

August 21, 2017
Nonalcoholic fatty liver disease is increasingly common. Approximately every third adult in industrialized countries has a morbidly fatty liver. This not only increases the risk of chronic liver diseases such as liver cirrhosis ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.